Proflexa
Proflexa, licence 80051669: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Sinoveda Canada Inc.
- NPN or DIN-HM
- 80051669
- Status
- Active licence
- Licence date
- 11 June 2014
- Revision date
- 17 November 2021
- Form
- Crème
- Route of administration
- Topique
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Commiphora myrrha Source : Stem resin Extraction ratio : 3:1 Dry plant equivalent : 51.3 mg | 17.1 mg | Not calculated |
| Carthamus tinctorius Source : Fleur Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 19.15 mg | 3.83 mg | Not calculated |
| DL-camphre | 30.0 mg | Not calculated |
| Boswellia sacra Source : Stem bark resin Extract : Matériel brut sec Extraction ratio : 7.0:1.0 Dry plant equivalent : 77.98 mg | 11.14 mg | Not calculated |
Non-medicinal ingredients
Beurre de karité, Olivate de sorbitan, Glycérine, Palmitate d'isopropyle, Benzoate de sodium, Hydroxyde de sodium, Alcool stéarylique, Gluconolactone, Éthanol, Olivate de cétéaryle, Extrait de graine de Pamplemousse, Triglycéride caprylique/caprique, Ethoxydiglycol, Hyaluronate de sodium, Stéarate citrate de glycéryle, Aqua, Huile de pépin de raisin, Gomme de xanthane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 0.5 mL ; maximum: 1.0 mL | minimum: 1.0 Jour(s) ; maximum: 3.0 Jour(s) |
Uses authorised in Canada
S.O
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051669
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.